Skip to content

Effect of driving pressure-guided lung protective ventilation strategy on postoperative atelectasis and oxygenation in patients undergoing thoracoscopic combined with laparoscopic esophagectomy

Effect of driving pressure-guided lung protective ventilation strategy on postoperative atelectasis and oxygenation in patients undergoing thoracoscopic combined with laparoscopic esophagectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092751
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-03-22
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

PEEP INCREMENTAL:During thoracoscopy and laparoscopy, PEEP titration is applied, starting from 0cm H2O and increasing by 1cmH2O each time, up to a maximum of 20cmH2O. Each PEEP level lasts for 5 respi
PEEP DECREMENTAL:During thoracoscopy and laparoscopy, PEEP titration is applied, starting from 20cm H2O and decreasing by 1cmH2O each time. Each PEEP level lasts for 5 respiratory cycles, and the driv
PEEP tidal volume:Drive pressure guide tidal volume control ventilation
PEEP of 5 cmH2O:The patient had a fixed PEEP of 5cmH2O throughout the entire surgical period, with tidal volume of 6ml/kg during one lung ventilation and tidal volume of 8ml/kg during two lung ventila

Sponsors

The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Age:18-75 years;?BMI=18.5-25kg/m2;? ASA:I-III;? time of one lung ventilation>1 hour;? Approved by the hospital ethics committee, the researcher agrees to sign a written consent form to participate in this study.

Exclusion criteria

Exclusion criteria: ? Patients with severe cardiovascular disease or severe liver and kidney dysfunction; ? History of serious complications in the past includes pulmonary infection, pleural effusion, atelectasis, respiratory failure, and cardiogenic pulmonary edema Contraindications for the use of positive end expiratory pressure (tension pneumothorax, pulmonary bullae, severe barotrauma, hypovolemic shock, bronchopleural fistula, high intracranial pressure); ? Intraoperative massive bleeding (greater than 500ml); ? Hemodynamic instability

Design outcomes

Primary

MeasureTime frame
Atelectasis;

Secondary

MeasureTime frame
Oxygenation index;Peak airway pressure;plateau pressure;end-expiratory positive pressure;Driving pressure;Pulmonary compliance;mean arterial pressure ;Heart rate;pulse oxygen saturation;Post-operative pulmonary complications;

Countries

China

Contacts

Public ContactSu Zhen

The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University

xzmcsuzhen@163.com+86 150 5266 9088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026